Assertio Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ASRT research report →
Companywww.assertiotx.com
Assertio Holdings, Inc. , a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.
- CEO
- Mark L. Reisenauer
- IPO
- 1997
- Employees
- 58
- HQ
- Lake Forest, IL, US
Price Chart
Valuation
- Market Cap
- $151.47M
- P/E
- -4.23
- P/S
- 1.48
- P/B
- 1.99
- EV/EBITDA
- 41.33
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 44.32%
- Op Margin
- -22.27%
- Net Margin
- -34.94%
- ROE
- -38.72%
- ROIC
- -18.97%
Growth & Income
- Revenue
- $118.71M · -5.00%
- Net Income
- $-30,375,000 · -40.75%
- EPS
- $-4.74 · -37.39%
- Op Income
- $-17,223,000
- FCF YoY
- -206.72%
Performance & Tape
- 52W High
- $23.46
- 52W Low
- $8.61
- 50D MA
- $18.24
- 200D MA
- $13.39
- Beta
- 0.45
- Avg Volume
- 272.61K
Get TickerSpark's AI analysis on ASRT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 13, 26 | Mason Heather L | other | 6,666 |
| May 13, 26 | Mason Heather L | other | 6,666 |
| May 5, 26 | Stark David Matthew | other | 4,851 |
| May 5, 26 | Emany Sravan Kumar | other | 4,851 |
| May 5, 26 | Kirk Sigurd | other | 4,851 |
| May 5, 26 | MCKEE WILLIAM | other | 4,851 |
| May 5, 26 | Mason Heather L | other | 4,851 |
| Mar 2, 26 | Schlessinger Sam | other | 21,128 |
| Mar 2, 26 | Schlessinger Sam | other | 18,804 |
| Mar 2, 26 | Patel Ajay | other | 21,128 |
Our ASRT Coverage
We haven't published any research on ASRT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ASRT Report →